Metformin Therapy Center

Metformin's primary safety concern in patients with impaired renal function is its ability to cause lactic acidosis. 

Glucose-lowering medication can influence COVID-19 pathogenesis and could have implications for treating patients with diabetes and COVID-19.

Metformin can bring on vitamin B12 deficiency by lowering vitamin B12 absorption in the gastrointestinal tract.

Metformin, used in the management of blood glucose, may provide a renoprotective effect through inhibition of inflammation and apoptosis.

Study examines the complex relationship between type 2 diabetes, metformin use, and breast cancer subtype.

A retrospective cohort analyzed the association of two commonly prescribed medications on heart failure outcomes in patients with reduced estimated glomerular filtration rate.

Metformin has been associated with a higher incidence of peripheral neuropathy.

Diabetes patients who were taking metformin before contracting Covid-19 had dramatically different outcomes.

Metformin is often associated with lactic acidosis, especially in patients with kidney disease. A recently published study questions this association in patients with mild to moderate disease.

Use of metformin was associated with a 16% reduced risk for overall mortality in patients with type 2 diabetes and pancreatic cancer.